sales@contrivedatuminsights.com
CDI - Contrive Datum Insights
Press ReleaseMedical Devices

Endoscopy Devices Market Forecast to USD 97.99 billion by 2034, Growing 6.8% a Year

36.5% of 2025 revenue sits in North America, and 13.92% growth in Robot Assisted Endoscopy Devices leads the product axis.

PUNE, INDIA — 21 AUGUST 2026CONTRIVE DATUM INSIGHTS

Market reaches USD 97.99 billion by 2034, up from USD 54.2 billion in 2025, at a 6.8% CAGR.

North America holds 36.5% of 2025 revenue at USD 19.78 billion.

Fastest growth: Robot Assisted Endoscopy Devices at 13.92% a year.

42% of 2025 revenue sits in Endoscopes, the largest product line.

Contrive Datum Insights has published "Endoscopy Devices Market Size, Share & Industry Analysis, By Product (Endoscopes, Disposable Endoscopy Devices, Robot Assisted Endoscopy Devices, Endoscopy Visualization Systems, Operative Devices), Application (Gastrointestinal (GI) endoscopy, Laparoscopy, Obstetrics/gynecology endoscopy, Arthroscopy, Urology endoscopy (cystoscopy), Bronchoscopy, Mediastinoscopy, Otoscopy, Laryngoscopy, Other applications), End-use (Hospitals, Ambulatory surgery center, Other end uses), Distribution channel (Direct Tenders, Distributor Sales), Technology (Standard Definition (SD) Systems, High Definition (HD) Systems, Ultra HD / 4K Systems), and Regional Forecast, 2026-2034". The study sizes the global endoscopy devices market at USD 54.2 billion in 2025 and projects growth from USD 57.89 billion in 2026 to USD 97.99 billion by 2034, a compound annual growth rate of 6.8% across the forecast period.

Endoscopy devices are the instruments, visualization systems and accessories used to examine and treat internal organs and cavities through minimally invasive access, spanning both flexible scopes used in gastrointestinal, pulmonary and urological procedures and rigid scopes used in laparoscopic, arthroscopic and gynecological surgery. The category includes the imaging hardware, such as light sources, cameras and monitors, that renders the procedure visible to the operating team, alongside the hand instruments and energy devices used to complete the intervention. Buyers are hospitals, ambulatory surgery centers and specialty clinics that purchase both capital equipment for procedure rooms and the disposable or reusable instruments consumed with each case.

Rising volume of gastrointestinal and minimally invasive procedures

Rising volume of gastrointestinal and minimally invasive procedures is the largest single contributor to the market's growth over the forecast period, and the study rates its impact high. Against a market growing at 6.8% a year, the product lines exposed to it move fastest: Robot Assisted Endoscopy Devices compounds at 13.92%, taking its share of revenue from 6% to 11% and its value from USD 3.25 billion to USD 10.78 billion.

On the upside, the study's bull case assumes robot-assisted and single-use platform adoption accelerates faster than the base case as more health systems commit capital budgets to replacing conventional endoscopy suites, which would take 2034 revenue to USD 109.75 billion rather than the USD 97.99 billion base case.

However, hospital capital spending tightens and ambulatory procedure migration slows, delaying replacement of existing reusable endoscope fleets and capital equipment upgrades, which would hold 2034 revenue to USD 88.19 billion. Endoscopes, which carries 42% of 2025 revenue, already grows at only 4.97% against the market's 6.8%, so the largest part of the base is also its slowest.

Key Players Compete on Endoscopes Volume and Robot Assisted Endoscopy Devices Growth

Competition in the global endoscopy devices market runs along the product axis rather than the regional one. Endoscopes holds 42% of 2025 revenue at USD 22.76 billion and remains the largest line through 2034 at 36%, making it the position hardest for a challenger to take. Robot Assisted Endoscopy Devices, growing at 13.92%, is where share actually changes hands. A supplier established in one is not thereby established in the other, which is what sustains a field of this size in a market of USD 54.2 billion.

Further Report Findings

SegmentLed 2025 byShare & valueFastest-growing
ProductEndoscopes42% · USD 22.76 billion
ApplicationGastrointestinal (GI) endoscopy34% · USD 18.43 billionBronchoscopy 12.14%
End-useHospitals62% · USD 33.6 billionAmbulatory surgery center 9.11%
Distribution channelDirect Tenders58% · USD 31.44 billionDistributor Sales 7.88%
TechnologyHigh Definition (HD) Systems58% · USD 31.44 billionUltra HD / 4K Systems 12.83%
  • Based on regional analysis, North America led the global endoscopy devices market in 2025 with 36.5% of global revenue at USD 19.78 billion, reaching USD 32.34 billion by 2034.
  • Asia Pacific takes a rising share of global revenue over the forecast period, from 27% in 2025 to 32% in 2034, with revenue growing from USD 14.63 billion to USD 31.36 billion.
  • Middle East and Africa remains the smallest region throughout, at 5.5% of 2025 revenue and 5.5% by 2034.
  • Robot Assisted Endoscopy Devices is projected to grow at 13.92% over the forecast period, the fastest of any product line.
  • The United States is the largest single country market at USD 17.41 billion in 2025, 32.12% of global revenue.

The report segments the market across five axes; by product, and by application, end-use, distribution channel and technology; with revenue and a growth rate for every line in every year from 2020 to 2034, alongside bear, base and bull scenarios for the headline total at USD 88.19 billion and USD 109.75 billion by 2034. It covers all five regions with country-level breakdowns, the competitive landscape, and the research methodology behind every estimate. Delivered as a PDF; a free sample is available on request.

Regions Covered
North AmericaEuropeAsia PacificLatin AmericaMiddle East and Africa
About Contrive Datum Insights

Contrive Datum Insights is a global market intelligence and consulting firm working across investment, information technology, healthcare and manufacturing markets. Every market we publish is sized twice — once top-down from the leading players and once bottom-up from the addressable base — and validated by primary interview. More about CDI.

Asia Pacific
Kunjir Shyama Prestine, Sr. no. 174/1
Jagtap Diary Road, Pimple Saudagar
Pune 411017, India
+91 983 481 6757
United States
21C2 Lakeshore Dr.
Farmington, CT 06032
United States
+1 215 297 4078